Recursion Pharmaceuticals (RXRX) News
NASDAQ: RXRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
4.36+0.41 (+10.38%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
RXRX news summary
We found 1 recent headline mentioning Recursion Pharmaceuticals (RXRX): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. RXRX is making an outsized move today, up 10.38% at $4.36, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Thursday Sector Laggards: Biotechnology, Packaging & Containers", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology